How do you pay?

How to pay the least

Ask for the cash price

Romvimza

We didn’t find one.

  1. Ask your pharmacy for Romvimza’s cash price, and one or two other pharmacies too.
  2. Romvimza’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameRomvimza
Authorized genericvimseltinib
Regular genericvimseltinib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Romvimza?
The original
–
–

Brand nameThe maker’s card

Deciphera AccessPoint Commercial Copay Program

Savings card from Deciphera Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on decipheraaccesspoint.com 

See the offer on decipheraaccesspoint.com

In the maker’s words

“Pay as little as $0 for ROMVIMZA, if eligible…”

From the maker’s offer on decipheraaccesspoint.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Romvimza itself, from the same company, sold without the brand name, and usually for less. For now Romvimza is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ROMVIMZA is a kinase inhibitor indicated for treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity.

Source: the FDA label for Romvimza (Deciphera Pharmaceuticals, LLC), June 26, 2026. Full label on DailyMed 

Good to know